physostigmine has been researched along with Depressive Disorder in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (71.43) | 18.7374 |
| 1990's | 6 (21.43) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barros, DM; Cordeiro, MF; Fernandes, SS; Kaszubowski, E; Koth, AP; Moreira, FP; Oses, JP; Parfitt, GM; Peixoto, CS; Soubhia, A; Wiener, CD | 1 |
| Addy, NA; Nunes, EJ; Wickham, RJ | 1 |
| MIDRIO, M; ZATTI, P | 1 |
| KLEIN, JR | 1 |
| Luchins, DJ | 1 |
| Gillin, JC; Janowsky, DS; Judd, LL; McClure, SF; Risch, SC | 1 |
| Spar, JE | 1 |
| Risch, SC | 1 |
| Spiegel, R | 1 |
| Berger, M; Bronisch, T; Lund, R; von Zerssen, D | 1 |
| Coco, A; Davis, KL; Deutsch, SI; Horvath, T; Levy, MI; Mohs, RC; Rothpearl, AB; Stockton, D | 1 |
| Berger, M; Doerr, P; von Zerssen, D | 1 |
| Berger, M; Bronisch, T; Doerr, P; Lund, R; von Zerssen, D | 1 |
| Gillin, JC; Mendelson, WB; Sitaram, N | 1 |
| Berger, PA; Hollister, LE; Johnson, AL | 1 |
| Bahro, M; Berger, M; Gann, H; Hohagen, F; Lis, S; Riemann, D; Stadmüller, G | 1 |
| Fritze, J; Lanczik, M; Riederer, P; Sofic, E; Struck, M | 1 |
| Bahro, M; Conway, A; Dukoff, R; Friz, J; Lasser, R; Peskind, ER; Sunderland, T; Wilkinson, CW | 1 |
| Britton, KT; Hauger, R; Irwin, M; Koob, GF; Pulvirenti, L; Swerdlow, NR | 1 |
| Minichiello, M; Molchan, SE; Sunderland, T; Vitiello, B | 1 |
| Hanin, I; Hasey, G | 1 |
| Janowsky, DS; Overstreet, DH; Rezvani, AH | 1 |
| Sikes, CR; Stokes, PE | 1 |
| Britton, KT; Downs, NS; Gibbs, DM; Koob, GF; Swerdlow, NR | 1 |
| Abramowitz, C; Davous, P; Lamour, Y; Piketty, ML; Roudier, M | 1 |
| Gillin, JC; Huey, L; Janowsky, DS; Rausch, J; Risch, SC; Ziegler, MG | 1 |
| Huey, LY; Janowsky, DS; Rausch, JL; Risch, SC | 1 |
| Huey, LY; Janowsky, DS; Kennedy, B; Risch, SC; Ziegler, M | 1 |
3 review(s) available for physostigmine and Depressive Disorder
| Article | Year |
|---|---|
The role of endogenous opioid systems in neuroendocrine regulation.
Topics: Adrenocorticotropic Hormone; beta-Endorphin; Brain; Corticotropin-Releasing Hormone; Depressive Disorder; Endorphins; Gonadotropins, Pituitary; Humans; Hypothalamo-Hypophyseal System; Hypothalamus; Neurotransmitter Agents; Physostigmine; Pituitary Gland; Pituitary-Adrenal System; Thyrotropin | 1983 |
Acetylcholine, sleep, and depression.
Topics: Acetylcholine; Animals; Arecoline; Arousal; Depressive Disorder; Humans; Models, Biological; Physostigmine; Reaction Time; Receptors, Muscarinic; Scopolamine; Sleep; Sleep Initiation and Maintenance Disorders; Sleep Stages; Sleep Wake Disorders; Sleep, REM | 1982 |
The hypothalamic-pituitary-adrenocortical axis in major depression.
Topics: Adrenocorticotropic Hormone; Body Fluids; Corticotropin-Releasing Hormone; Depressive Disorder; Estrenes; Humans; Hypothalamo-Hypophyseal System; Metyrapone; Mifepristone; Physostigmine; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Vasopressins | 1988 |
3 trial(s) available for physostigmine and Depressive Disorder
| Article | Year |
|---|---|
[Prediction of treatment outcome with antidepressants: are short REM latencies diagnostically and prognostically reliable indicators?].
Topics: Adult; Age Factors; Amitriptyline; Antidepressive Agents; Arecoline; Clinical Trials as Topic; Depressive Disorder; Diagnosis, Differential; Drug Evaluation; Humans; Male; Physostigmine; Prognosis; Sleep, REM; Syndrome; Time Factors | 1984 |
Cholinergic neurotransmission, REM sleep and depression.
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Brain Stem; Cholinergic Agonists; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Mental Disorders; Middle Aged; Parasympathomimetics; Physostigmine; Polysomnography; Reaction Time; Receptors, Muscarinic; Sleep Stages; Sleep Wake Disorders; Sleep, REM; Succinimides; Synaptic Transmission; Tacrine | 1994 |
Cholinergic neurotransmission seems not to be involved in depression but possibly in personality.
Topics: Acetylcholine; Adolescent; Adult; Aged; Arousal; Biperiden; Cholinergic Fibers; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Mianserin; Middle Aged; Personality; Physostigmine; Synaptic Transmission; Viloxazine | 1995 |
22 other study(ies) available for physostigmine and Depressive Disorder
| Article | Year |
|---|---|
Enhanced cholinergic-tone during the stress induce a depressive-like state in mice.
Topics: Acetylcholinesterase; Anhedonia; Animals; Anxiety; Cholinesterase Inhibitors; Depressive Disorder; Disease Models, Animal; Dominance-Subordination; Helplessness, Learned; Hydrocortisone; Male; Mice, Inbred C57BL; Motor Activity; Physostigmine; Random Allocation; Stress, Psychological | 2018 |
Ventral tegmental area cholinergic mechanisms mediate behavioral responses in the forced swim test.
Topics: Acetylcholine; Animals; Cholinergic Antagonists; Cholinesterase Inhibitors; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Locomotion; Male; Mecamylamine; Neuropsychological Tests; Nicotinic Antagonists; Physostigmine; Rats, Sprague-Dawley; Scopolamine; Swimming; Ventral Tegmental Area | 2015 |
[Influence of Ca ions on depression of neuromuscular transmission by anticholinesterases].
Topics: Calcium; Calcium, Dietary; Cholinesterase Inhibitors; Cholinesterases; Depressive Disorder; Humans; Ions; Isoflurophate; Neostigmine; Neuromuscular Junction; Parasympathomimetics; Physostigmine | 1962 |
Depression of heme formation and production of free porphyrin in duck erythrocytes.
Topics: Adenine; Animals; Benzimidazoles; Chloramphenicol; Depression; Depressive Disorder; Ducks; Erythrocytes; Heme; Nucleosides; Physostigmine; Porphyrins; Pyridoxine | 1962 |
Developments in biological psychiatry: clinical applications to the major psychoses.
Topics: Amphetamine; Antidepressive Agents; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Humans; Hydrocortisone; Lithium; Neurotransmitter Agents; Physostigmine; Psychotic Disorders; Research; Schizophrenia; Tomography, X-Ray Computed | 1982 |
Dementia in the aged.
Topics: Aged; Cerebral Infarction; Choline; Creutzfeldt-Jakob Syndrome; Dementia; Depressive Disorder; Diagnosis, Differential; Humans; Huntington Disease; Phosphatidylcholines; Physostigmine; Psychoses, Substance-Induced | 1982 |
beta-Endorphin hypersecretion in depression: possible cholinergic mechanisms.
Topics: Adrenocorticotropic Hormone; beta-Endorphin; Depressive Disorder; Double-Blind Method; Endorphins; Humans; Physostigmine; Psychotic Disorders; Random Allocation; Receptors, Cholinergic | 1982 |
REM latency in neurotic and endogenous depression and the cholinergic REM induction test.
Topics: Adult; Depressive Disorder; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Physostigmine; Reaction Time; Sleep, REM | 1983 |
Acetylcholinesterase activity in CSF in schizophrenia, depression, Alzheimer's disease and normals.
Topics: Acetylcholinesterase; Adult; Aged; Alzheimer Disease; Cerebrospinal Fluid Proteins; Cholinesterase Inhibitors; Depressive Disorder; Dyskinesia, Drug-Induced; Humans; Middle Aged; Physostigmine; Schizophrenia | 1983 |
Physostigmine's influence on DST results.
Topics: Depressive Disorder; Dexamethasone; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol; Physostigmine | 1984 |
Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?
Topics: Adult; Body Weight; Depressive Disorder; Dexamethasone; Diagnosis, Differential; Electroencephalography; Electromyography; Growth Hormone; Humans; Hydrocortisone; Insulin; Middle Aged; Physostigmine; Sleep Stages; Sleep, REM | 1982 |
The anticholinergic intoxication syndrome: diagnosis and treatment.
Topics: Aged; Benztropine; Depressive Disorder; Humans; Male; Parasympatholytics; Physostigmine; Syndrome; Thiothixene; Urination Disorders | 1981 |
Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
Topics: Aged; Aging; Brief Psychiatric Rating Scale; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Female; Glycopyrrolate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Injections, Intravenous; Male; Muscarinic Antagonists; Neuronal Plasticity; Physostigmine; Pituitary-Adrenal System; Presynaptic Terminals; Receptors, Muscarinic; Scopolamine; Severity of Illness Index; Time Factors; Up-Regulation | 1999 |
Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication.
Topics: Adrenocorticotropic Hormone; Amphetamine; Animals; Biomarkers; Body Weight; Brain Chemistry; Corticotropin-Releasing Hormone; Depressive Disorder; Endocrine Glands; Immune System; In Vitro Techniques; Killer Cells, Natural; Male; Physostigmine; Prolactin; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome | 1991 |
Reciprocal changes in psychosis and mood after physostigmine in a patient with Alzheimer's disease.
Topics: Alzheimer Disease; Depressive Disorder; Female; Humans; Middle Aged; Physostigmine; Psychiatric Status Rating Scales | 1991 |
The cholinergic-adrenergic hypothesis of depression reexamined using clonidine, metoprolol, and physostigmine in an animal model.
Topics: Acetylcholine; Animals; Brain; Clonidine; Depressive Disorder; Male; Metoprolol; Models, Biological; Neostigmine; Norepinephrine; Physostigmine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Cholinergic | 1991 |
Alcoholism and depressive disorders: is cholinergic sensitivity a biological marker?
Topics: Acetylcholine; Alcoholism; Arousal; Body Temperature Regulation; Brain; Cholinergic Fibers; Depressive Disorder; Evoked Potentials, Auditory; Humans; Physostigmine; Reaction Time; Receptors, Cholinergic; Sleep, REM | 1989 |
Supersensitive endocrine response to physostigmine in dopamine-depleted rats: a model of depression?
Topics: Adrenocorticotropic Hormone; Animals; Brain Chemistry; Depressive Disorder; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Male; Norepinephrine; Oxidopamine; Physostigmine; Prolactin; Rats; Rats, Inbred Strains | 1986 |
Pharmacological modulation of cortisol secretion and dexamethasone suppression in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Clonidine; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Male; Physostigmine | 1988 |
Physostigmine-induced epinephrine release in patients with affective disorder.
Topics: Adult; Bipolar Disorder; Depressive Disorder; Diagnosis, Differential; Epinephrine; Humans; Infusions, Parenteral; Middle Aged; Norepinephrine; Physostigmine; Psychotic Disorders | 1986 |
A kinetic analysis and replication of decreased platelet serotonin uptake in depressed patients.
Topics: Bipolar Disorder; Blood Platelets; Depressive Disorder; Humans; Kinetics; Mental Disorders; Mood Disorders; Physostigmine; Serotonin | 1986 |
Effects of physostigmine on pulse, blood pressure, and serum epinephrine levels.
Topics: Adult; Alzheimer Disease; Arrhythmias, Cardiac; Blood Pressure; Depressive Disorder; Epinephrine; Humans; Hypertension; Middle Aged; N-Methylscopolamine; Parasympatholytics; Physostigmine; Pulse; Scopolamine Derivatives | 1985 |